WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that J. Donald deBethizy, Ph.D., President and Chief Executive Officer, is scheduled to present at the 12th Annual BIO CEO and Investor Conference at The Waldorf Astoria hotel in New York City on Tuesday, February 9, 2010 at 3:00 p.m. Eastern Standard Time.
